Nevirapine was believed to carry high risks of hepatotoxicity and Steven Johnson Syndrome, particularly in women with a higher CD4 count > 250 cells/mm3, which were not necessarily balanced against an unclear teratogenicity risk 27, 28. This evidence concerns the gene CD4 and Stevens-Johnson syndrome.